Veracyte (VCYT) SVP and General Counsel sells 6,658 shares in pre-set plan

Rhea-AI Filing Summary

VERACYTE, INC. senior vice president and general counsel Annie McGuire reported selling 6,658 shares of common stock in open-market transactions on March 4, 2026. The sales were made under a Rule 10b5-1 trading plan adopted on August 29, 2025.

The reported weighted average sale prices were $35.2936 per share for 4,994 shares and $36.3393 per share for 1,664 shares. After these sales, McGuire directly owned 94,706 shares of Veracyte common stock.

Insider Trade Summary

Net Seller: 6,658 shares ($236,725)

Net Sell 2 txns

Insider McGuire Annie

Role SVP, General Counsel

Sold 6,658 shs ($237K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,994	$35.2936	$176K
Sale	Common Stock	1,664	$36.3393	$60K

Holdings After Transaction: Common Stock — 96,370 shares (Direct)

Footnotes (1)

1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $36.17 to $36.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McGuire Annie

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		S(1)		4,994	D	$35.2936(2)	96,370	D
Common Stock	03/04/2026		S(1)		1,664	D	$36.3393(3)	94,706	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.

2. Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

3. Represents weighted average sales price. Sale prices for the transactions range from $36.17 to $36.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transaction did Veracyte (VCYT) report for Annie McGuire?

Veracyte reported that SVP and General Counsel Annie McGuire sold 6,658 shares of common stock in open-market transactions on March 4, 2026, through a pre-arranged Rule 10b5-1 trading plan.

At what prices did Annie McGuire sell Veracyte (VCYT) shares?

Annie McGuire’s Veracyte share sales used weighted average prices of $35.2936 for 4,994 shares and $36.3393 for 1,664 shares, with individual trade prices ranging from $35.00–$35.89 and $36.17–$36.48, respectively.

How many Veracyte (VCYT) shares does Annie McGuire own after the Form 4 transactions?

After the reported sales, Annie McGuire directly owns 94,706 shares of Veracyte common stock. This figure reflects her updated direct ownership following the total sale of 6,658 shares disclosed in the Form 4 filing.

Was the Veracyte (VCYT) insider sale by Annie McGuire under a Rule 10b5-1 plan?

Yes. The Form 4 states the transactions were conducted under a Rule 10b5-1 trading plan adopted by Annie McGuire on August 29, 2025, indicating the sales were pre-arranged rather than discretionary trades.

What role does Annie McGuire hold at Veracyte (VCYT) in this Form 4?

In this Form 4, Annie McGuire is identified as Veracyte’s senior vice president and general counsel. The reported transactions involve her direct ownership of Veracyte common stock, classified as non-derivative securities.

How many separate sale transactions did Veracyte (VCYT) disclose for Annie McGuire?

The Form 4 discloses two open-market sale transactions for Annie McGuire on March 4, 2026, one for 4,994 shares and another for 1,664 shares, both involving Veracyte common stock held directly.